These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 36523986)

  • 21. Gut microbiota and its therapeutic implications in tumor microenvironment interactions.
    Feng P; Xue X; Bukhari I; Qiu C; Li Y; Zheng P; Mi Y
    Front Microbiol; 2024; 15():1287077. PubMed ID: 38322318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immuno-oncology-microbiome axis of gastrointestinal malignancy.
    Lin Q; Guan SW; Yu HB
    World J Gastrointest Oncol; 2023 May; 15(5):757-775. PubMed ID: 37275452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy.
    Chen J; Li T; Liang J; Huang Q; Huang JD; Ke Y; Sun H
    Biomed Pharmacother; 2022 Jan; 145():112443. PubMed ID: 34847476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Influence of the Microbiome on Immunotherapy for Gastroesophageal Cancer.
    Dadgar N; Edlukudige Keshava V; Raj MS; Wagner PL
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment.
    Luu M; Schütz B; Lauth M; Visekruna A
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host-Microbiome Interaction in Lung Cancer.
    Dong Q; Chen ES; Zhao C; Jin C
    Front Immunol; 2021; 12():679829. PubMed ID: 34108973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
    Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
    Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
    Rao Malla R; Marni R; Kumari S; Chakraborty A; Lalitha P
    Clin Breast Cancer; 2022 Apr; 22(3):200-211. PubMed ID: 34625387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications.
    Amara S; Yang LV; Tiriveedhi V; Muzaffar M
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unravelling the role of intratumoral bacteria in digestive system cancers: current insights and future perspectives.
    Lu W; Aihaiti A; Abudukeranmu P; Liu Y; Gao H
    J Transl Med; 2024 Jun; 22(1):545. PubMed ID: 38849871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.
    Ciernikova S; Novisedlakova M; Cholujova D; Stevurkova V; Mego M
    Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33287196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
    Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
    J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of the Cervicovaginal and Gut Microbiome in Cervical Intraepithelial Neoplasia and Cervical Cancer.
    Sims TT; Colbert LE; Klopp AH
    J Immunother Precis Oncol; 2021 May; 4(2):72-78. PubMed ID: 35663536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orally Administrated Hydrogel Harnessing Intratumoral Microbiome and Microbiota-Related Immune Responses for Potentiated Colorectal Cancer Treatment.
    Li L; He S; Liao B; Wang M; Lin H; Hu B; Lan X; Shu Z; Zhang C; Yu M; Zou Z
    Research (Wash D C); 2024; 7():0364. PubMed ID: 38721274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
    Liu L; Shah K
    JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions.
    Fu Y; Li J; Cai W; Huang Y; Liu X; Ma Z; Tang Z; Bian X; Zheng J; Jiang J; Li C
    Acta Pharm Sin B; 2024 Apr; 14(4):1560-1591. PubMed ID: 38572104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.
    Sevcikova A; Izoldova N; Stevurkova V; Kasperova B; Chovanec M; Ciernikova S; Mego M
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
    Gately S
    Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.